drugset / Trial / NCT00663598

Levitra® - Real Life Safety and Efficacy of Levitra

NCT00663598

Phase 4 Completed 30825 enrolled Bayer
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Collect data on safety, efficacy, and subject acceptance of vardenafil treatment under daily life conditions in a large number of subjects with erectile dysfunction (ED)

Timeline

Start
2003-10
Primary completion
Completion
2004-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Vardenafil Small molecule

Indications